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Background:  Activated platelets initiate thrombus formation in atherosclerotic diseases has been linked to serious clinical events. Molecular 
imaging of activated platelet could be valuable to identify high-risk plaques before the onset of clinical events. We hypothesized that microbubbles 
targeted to activated platelet with contrast-enhanced ultrasound (CEU) could noninvasive in vivo visualization of thrombus formation to identify 
vulnerable atherosclerotic plaques.
Methods:  Thrombus was induced in 18 C57BL/6 mice via topical application of arachidonic acid (AA) on the carotid. Thrombus formation was 
imaged with intravital fluorescence microscopy using calcein AM incubated platelets. Targeted microbubbles to glycoprotein _IIb`3, which is over-
expressed on activated platelets, were modified covalently with cyclic RGD peptide (MBRGD). Control microbubbles were conjugated with nonspecific 
peptide (MBCON). Flow chamber studies were performed to assess attachment of MBRGD and MBCON to glycoprotein _IIb`3 (shear stress 2dyn/
cm2). In vivo CEU imaging was performed at 15 minutes after microbubbles injection. The contralateral carotid with sham surgery served as control.
Results:  Fluorescence microscopy confirmed that activated platelets immediately started adhering arterial wall after AA application. Thrombus in 
the AA treated artery was clearly noted by histology but not in the control artery. In flow chamber experiments, there was 4-folds greater attachment 
of MBRGD to the glycoprotein _IIb`3 as compared to MBCON (P<0.05). There were significant differences in VI of the MBRGD between thrombotic 
and sham surgery carotid artery (17.5±3.3 vs 3.2±1.6, P<0.05) at 15 minutes after microbubbles injection. As expected, VI of the MBRGD was 
significantly higher than that of MBCON (17.5±3.3 vs 7.1±2.4, P<0.05) in thrombotic carotid artery.
Conclusions:  Activated platelet can be detected by CEU molecular imaging with microbubbles targeted to glycoprotein _IIb`3. Target-specific 
CEU imaging of activated platelet may be useful for non-invasive detection of high risk and vulnerable atherosclerotic plaques.
